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A randomized controlled trial examining Iyengar
yoga for young adults with rheumatoid arthritis:
a study protocol
Subhadra Evans*, Laura Cousins, Jennie CI Tsao, Saskia Subramanian, Beth Sternlieb, Lonnie K Zeltzer
Abstract
Background: Rheumatoid arthritis is a chronic, disabling disease that can compromise mobility, daily functioning,
and health-related quality of life, especially in older adolescents and young adults. In this project, we will compare
a standardized Iyengar yoga program for young people with rheumatoid arthritis to a standard care wait-list
control condition.
Methods/Design: Seventy rheumatoid arthritis patients aged 16-35 years will be randomized into either the
6-week Iyengar yoga program (12 - 1.5 hour sessions twice weekly) or the 6-week wait-list control condition. A
20% attrition rate is anticipated. The wait-list group will receive the yoga program following completion of the first
arm of the study. We will collect data quantitatively, using questionnaires and markers of disease activity, and
qualitatively using semi-structured interviews. Assessments include standardized measures of general and arthritis-
specific function, pain, mood, and health-related quality of life, as well as qualitative interviews, blood pressure/
resting heart rate measurements, a medical exam and the assessment of pro-inflammatory cytokines. Data will be
collected three times: before treatment, post-treatment, and two months following the treatment.
Discussion: Results from this study will provide critical data on non-pharmacologic methods for enhancing
function in rheumatoid arthritis patients. In particular, results will shed light on the feasibility and potential efficacy
of a novel intervention for rheumatoid arthritis symptoms, paving the way for a larger clinical trial.
Trial Registration: ClinicalTrials.gov NCT01096823
Background
Rheumatoid arthritis (RA) is a chronic autoimmune dis-
order affecting over 2 million adults in the United
States. Symptoms include pain, swelling, stiffness, and
loss of joint function. Disability and diminished health-
related quality of life (HRQOL) are commonly experi-
enced. While RA is more typically diagnosed in older
adults, many young people are also affected. Using an
estimated annual prevalence of 1.3% for those under 25
years of age derived from the National Health Interview
Survey, close to 400,000 children, adolescents and young
adults suffer from arthritis in the U.S. [1].
The economic and personal burden of rheumatoid
arthritis is high across adult and pediatric populations
[2] but RA may be particularly burdensome to youth.
Pain, compromised physical functioning, depression and
social isolation commonly occur in affected adolescents
[3,4]. Young people with arthritis or rheumatism have
increased depression and pain, are more likely to use
health-care services, and are less likely to attend school
compared to healthy controls and also compared to ado-
lescents with other chronic diseases [3]. An additional
concern for young people with RA is the challenge to
meet normative developmental milestones, such as inde-
pendence. Pain and debilitated functioning may leave
many in a socially and emotionally compromised state
[5]. Such difficulties often persist into later adulthood.
Pediatric patients with arthritis are at long-term risk of
compromised physical and psychosocial functioning,
including decreased rates of employment in the future
[4]. Although the maintenance of physical functioning is
especially important to prevent future osteoporosis and
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wheelchair dependency in young RA patients, the reali-
ties of mobility limitations often impedes this [6].
Clearly, young people with RA require rehabilitation
efforts that target psychological and physical
functioning.
Despite the need for physical and psychosocial
treatments aimed at adolescents and young adults with
RA, traditional approaches remain limited [6]. Current
medications, including non-steroidal anti-inflammatory
drugs (NSAIDs), disease-modifying rheumatic drugs
(DMARDs) and steroid treatments can be useful in les-
sening pain and stiffness, but adverse events such as
gastrointestinal problems commonly occur [7]. Such
adverse side effects may compound young patients’
already compromised HRQOL. Even for patients who
respond well to drugs, pharmacologic therapy is often
not enough. Rehabilitation efforts that promote a range
of physical outcomes including ambulation, muscle
strength and balance are often required to prevent joint
weakness, reduced muscle efficiency, and ultimately
future disability [6]. Yoga is particularly suited to meet-
ing these rehabilitation needs, as poses designed to
increase the strength and mobility of joints and muscles
can be individualized to meet each patient’s abilities and
needs. As reviewed below, yoga has the additional
advantage of addressing the patient’s psychospiritual
functioning, which may further reduce risk of disability.
Yoga as treatment for chronic conditions
Yoga is a discipline developed in ancient India, charac-
terized as a science of self-study and awareness through
asanas (body postures), pranayama (patterns of breath-
ing), and meditation. Yoga has been embraced in Wes-
tern settings as a form of exercise and relaxation.
Currently, yoga programs are relatively low cost, widely
available and safe, when performed properly.
Only a few studies have focused on the impact of yoga
on musculoskeletal conditions and none have focused
specifically on young people. One study in RA patients
did include adolescents but the age range was too broad
(aged 15-72 years) to generalize the findings across age
groups [8]. Despite the small number of participants in
this study (10 in each of the yoga and control groups),
yoga significantly improved handgrip strength. Handgrip
strength was also significantly improved in 20 patients
aged 23-43 years following yoga compared to controls
[9]. Garfinkel and colleagues tested IY for 20 patients
with osteoarthritis of the hands [10] and 17 patients
with carpal tunnel syndrome [11]; both studies resulted
in amelioration of pain and improved mobility. In 101
chronic back pain patients (aged 27-57), yoga led to
improved back-related functioning, compared to an
exercise control group and an education group; at
26 weeks post-intervention the yoga group further
demonstrated improved pain bother and functioning
compared to controls [12]. In an Iyengar yoga program
for 7 patients with osteoarthritis aged 50+ years [13],
significant reductions were found across functioning and
pain scales. In 60 patients with chronic low back pain
aged 23-67 years, Williams et al. [14] found significant
improvements for an IYP compared to a control group
receiving educational materials; over three quarters
reported improved functionality, over half experienced
reduced pain, and nearly 90% reduced pain medication.
Kuttner and colleagues [15] provided the only sys-
tematic analysis of the use of yoga for pain conditions
in children and adolescents (25 IBS patients aged 11-18
years). This intervention consisted of a 4-week home
practice of yoga, subsequent to an initial training ses-
sion. It is unclear to what degree participants actually
practiced yoga and to what extent they adhered to the
prescribed yoga protocol. Despite these limitations,
Kuttner et al. found that the yoga group exhibited sig-
nificantly reduced IBS symptoms and disability, and
improved coping and anxiety relative to wait-list
controls.
Limitations of extant research on yoga for health
conditions
Among the most important limitations of the existing
work on yoga are: 1) inadequate sample size; 2) overly
broad age range (e.g., inclusion of adolescents and
elderly patients in the same sample); 3) lack of specifica-
tion regarding the tradition of yoga utilized for all but
five prior studies [10-14]; 4) lack of a theoretical model
to inform treatment implementation and assessment of
outcomes. Since there is great variation across the
numerous traditions of yoga, a lack of standardization
can confound interpretations of the overall efficacy of
yoga on illness states. Unlike most other studies that
failed to specify the school of yogic movement utilized,
we will develop an IYP with a specific set of poses that
will allow reproducibility. In summary, we will address
the above gaps in the literature by testing the efficacy of
a standardized IYP (described below) in a well-defined
population with appropriate sample size (see Power/
Sample Size Calculation). Moreover, we have developed
a conceptual model delineating the potential mechan-
isms related to the IYP to guide our proposed research.
Biopsychosocial model of disability and pain
As a chronic condition, RA is best understood from a
biopsychosocial perspective– i.e., that psychological, bio-
logical, and social factors interact in the etiology and
maintenance of RA. The biopsychosocial model has
been used to understand disability, pain and treatment
options for a range of chronic illnesses, including RA
[16]. The conceptual model for our current study is
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similarly built within the biopsychosocial model [17]. It
is estimated that psychosocial factors contribute up to
20% of the disability associated with RA [18,19]. Thus,
an integrative treatment strategy for patients with RA is
warranted. IY is a non-pharmacological rehabilitation
intervention that can be combined with a conventional
treatment plan. Under the conceptual model (see
Figure 1), IY is viewed as impacting physical and psy-
chospiritual well-being. Improvements in these domains
in turn can lead to improvements in outcomes. The
model offers a guiding heuristic for how we conceptua-
lize the benefits of IYP for RA. We do not propose to
test each pathway depicted in this preliminary study nor
does the model depict all possible pathways. However,
in future larger trials which will incorporate the findings
of the present investigation, we plan to refine the con-
ceptual model and test specific pathways by which yoga
leads to beneficial outcomes for RA.
Physiological mechanisms in yoga practice
It is thought that IY quiets the body as well as the mind
through attention and relaxation [20]. Hence, yoga has
been associated with a number of physical benefits
including lowered autonomic arousal (including
decreased diastolic and systolic blood pressure and
decreased heart rate) [21-23] and a reduction in inflam-
matory responses in both healthy individuals [24] and
those with disease [25]. A recent review concluded that
yoga provides psychophysiological benefits that are par-
ticularly apparent for people with musculoskeletal con-
ditions [26].
Psychosocial benefits of yoga
IY has demonstrated positive effects on psychological
functioning including increased self-efficacy, or the ten-
dency to persist in health behaviors despite obstacles,
and improved coping and mood. In our previous work,
we [27] reported reduced depression and anxiety after a
5-week IYP. Similarly, Shapiro [28] found that a 20-
week IYP led to reductions in depression, anger, anxiety,
and neurotic symptoms in 17 patients (aged 20-71
years). Two other studies found significant improve-
ments in depression, anxiety and self-efficacy following
yoga [29,30]. Yoga is also associated with increased cop-
ing in patients [15,31-33]. Positive psychology, in turn,
is related to better physical functioning [34]. Thus, we
expect that yoga will enhance patients’ coping, mood
and self-efficacy, all of which will impact positively on
illness-related functioning. Exercise performed in a
group can also promote feelings of social well-being -
important for functional status in chronic disease [35].
In future large-scale trials, we will control for such
group effects, allowing us to determine the extent to
which social benefits of yoga are responsible for
improvements.
In contrast to established rehabilitation approaches
such as exercise or physical therapy, yoga incorporates
spiritual aspects that are purported to confer specific
benefits including increased acceptance and mindful-
ness. IY leads to skill in mastering the challenges of life,
which may extend to dealing with chronic illness and
pain [26]. It is anticipated that the IYP will enhance
patients’ compassionate understanding or acceptance of
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Figure 1 Conceptual model of Iyengar yoga for RA.
Evans et al. Trials 2011, 12:19
http://www.trialsjournal.com/content/12/1/19
Page 3 of 16
one’s health condition, which involves noting the pain
without avoidance or limited participation in life goals
[36]. Such acceptance appears to be a particularly
important facet of quality of life in coping with chronic
health conditions [37]. Yoga is also associated with
mindful awareness, a concept that has been integrated
in empirically validated approaches including cognitive-
behavioral therapy [38]. Mindfulness is an openness or
receptive awareness to what is occurring in the present.
Mindful activity has been found to improve mood and
stress [39], likely through strengthening attention on the
present [20]. Use and control of attention can be turned
towards minimizing stress, disability and pain. It is
anticipated that IY will lead to an increase in mindful-
ness and acceptance which will, in turn, improve func-
tioning among AYA with RA.
Yoga as an innovative approach
Scientists have long recognized the health benefits of
exercise for managing chronic conditions, including RA
[40]. In addition to positive effects on structural and
physical outcomes, exercise likely impacts brain chemis-
try to regulate somatomotor-sympathetic circuits and
promote psychological health [41]. We propose that
yoga shares many of these health benefits, in addition to
psychospiritual effects that are specific to yoga practice,
including mindfulness and acceptance. A further pur-
ported achievement of yoga, but not other forms of phy-
sical activity, includes control over physiological systems.
Maintaining postures is thought to lead to strengthening
and relaxation of voluntary muscles, and eventually to
ANS control [42]. Preliminary support for this notion
exists with research demonstrating voluntary control
over heart rate after a 30-day yoga intervention [43].
Other benefits specific to yoga practice include a non-
stressful form of physical activity that promotes an
increased alignment of joints and the exploring of con-
scious and/or unconscious gripping or tension in the
body. Such awareness can lead to the release of stress
and pain in the body, as well as learning to use bodily
systems more effectively. The combination of body,
mind and breath awareness in yoga is thought to act on
biological and psychospiritual systems to produce home-
ostasis across multiple aspects of an individual’s func-
tioning and physiology [26]. IY thus represents a
particularly promising approach for improving RA
HRQOL across multiple domains.
The specific aims of this research are to
1: Determine the feasibility of a six-week twice weekly
(12 session) IYP administered in a group format to
older adolescents and young adults with RA.
2: Compare the impact of IYP on the primary out-
comes of functioning and HRQOL to that of a wait-list
control group receiving usual care. Functioning will be
assessed by two standardized self-report measures, one
of general pain-related functioning and the other of
arthritis-specific functioning.
3: Evaluate the effects of IYP on secondary outcomes
of disease activity, pain and mood.
The hypotheses to be tested are
1: The IYP will be safe, acceptable and feasible: at least
80% of subjects will complete the IYP.
2: Following the IYP, participants will show significant
improvement on the primary outcomes of general func-
tioning, arthritis functioning and HRQOL relative to
controls. The benefits will be apparent post-treatment
and at two-month follow-up.
3: Following the IYP, participants will report signifi-
cant improvement on the secondary outcomes of pain,
DAS28, and mood compared to controls. These
improvements will be evident at both post-treatment
and at two-month follow-up.
Rationale
The proposed study is innovative as it will be the first
controlled investigation of a group-based, standardized
IYP for older adolescents and young adults with RA. IY
is a tradition of yoga that is unique in its emphasis on
precise anatomical alignment, use of supportive props,
and specific sequences of asanas (postures) (see detailed
description below). An additional innovation is the use
of a mixed-methods approach: patient outcomes and
predictors of treatment response will be assessed using
both quantitative (standardized questionnaires, physician
exam, blood pressure/resting heart rate, assessment of
erythrocyte sedimentation rate (ESR) and pro-inflamma-
tory cytokines) and qualitative (interview) methods.
The selection of young patients with RA is based on
key considerations. First, young people are likely to be
highly motivated as RA impinges upon social, emotional
and physical functioning in ways that differentiate them
from their peer groups. Second, the stamina/vigor atten-
dant with youth should enhance the ability of young
people to practice IY. Third, an age group beginning at
older adolescence is generally able to provide their own
transportation thereby improving class attendance.
Finally, in our previous work we found yoga to be very
well-received by young persons [44]. Our preliminary
results suggest that yoga is especially well-suited to
improving HRQOL and functioning in the proposed age
group.
Quality of life and functioning were chosen as the pri-
mary outcomes due to the chronic nature of RA and the
recent emphasis on patient-reported outcomes in clini-
cal research [45]. HRQOL is perhaps the most signifi-
cant construct in monitoring a chronic disease’s impact
[46]. The increased risk of behavioral and emotional dis-
orders faced by youth with chronic illnesses [47]
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underscores the need to assess and improve HRQOL,
including physical, emotional and behavioral functioning.
We also intend to examine biomarkers of the disease,
including DAS28 scores (see Secondary Outcomes below)
and pro-inflammatory cytokine responses before and after
the intervention. Cytokines and their receptors likely play
a role in the development and maintenance of the inflam-
matory process in RA [48]. Levels of interleukin-6 (IL-6)
and interleukin-1 receptor antagonist (IL-1 RA) are least
likely to be affected by biological agents used to treat RA
and will be explored as a potential mechanism in the effect
of yoga upon patient functioning.
In this study, the control condition will involve
patients receiving on-going care as usual for the length
of the yoga intervention. While we recognize that the
control group will not account for the social aspects of
the group-administered IYP, a usual care control group
is necessary at this early stage of the clinical trial pro-
cess. Usual care control groups are appropriate when
initially testing novel interventions [49]. If the IY pro-
gram is found to be superior to the wait-list group in
this exploratory study, a future large-scale study will
incorporate a control condition that accounts for the
social, attention and expectation effects of a group-
based intervention.
The overarching aim of the proposed study is to col-
lect preliminary data on the feasibility, safety and effi-
cacy of yoga for RA in patients aged 16-35 years to
inform a larger clinical trial. Another key aim of this
research is to develop a standardized yoga protocol that
may be easily disseminated to other settings for future
multi-center studies. The ultimate goal of this research
is to begin building a strong evidence base for a readily
transportable yoga treatment protocol that may be
incorporated within the conventional clinical manage-
ment of RA.
Study design and methods
Overview
This R21 project will consist of three phases: 1) treat-
ment manual development; 2) initial administration and
refinement of treatment; 3) a pilot study to evaluate
treatment outcome compared to an attention wait-list
control condition. These three phases are briefly sum-
marized below.
Phase one (3 months)
During this phase, the initial version of the manual
will be written. Based on our preliminary studies
described above, this manual will describe yoga,
breath and meditation exercises that are consistent
with specific needs of young RA patients. Attention
will also be given to how the poses can best be mod-
ified to ensure patients’ joints and areas of weakness
are protected. The manual will be developed by the
study yoga teacher, who will review the intervention
with senior Iyengar yoga teachers. During this phase,
we will also develop a protocol to evaluate IY
instructors’ adherence to the manual.
Phase two (3 Months)
We will further develop the protocol by conducting
an initial IY group. We will also train an additional
experienced IY instructor and two assistant instruc-
tors. The two IY teachers, with their assistants, will
teach a small class of 3 AYA RA patients each (total
n = 6) to refine the protocol. The purpose of the
assistant instructors is threefold: to promote class
safety by assisting patients safely in and out of poses
and to record adverse events to bring to the atten-
tion of the Safety Board (described below); to take
class attendance for determination of patient adher-
ence; and to record the poses and modifications
used in each class to be evaluated by the Board
(described below) for teacher adherence to the core
set of poses. The assistants will note for each stu-
dent: which poses were performed, which props
were used, and any difficulties experienced. Weekly
team meetings chaired by the PI will be conducted
to solicit suggestions on additional refinements to
the protocol.
Phase three (18 Months)
In this final phase, IY teachers will administer the
IYP using the revised manual to 70 participants who
will be assigned to either treatment (n = 35) or
usual care control (n = 35). The controls will be
immediately assigned to IYP at the end of the con-
trol phase (see Figure 2).
Design
A randomized control trial (RCT) design will be used to
examine the impact of IYP for adolescents and young
adults aged 16-35 years with RA on the primary out-
comes of general and arthritis-specific functioning, and
the secondary outcomes of DAS28, pain and mood.
The overall design of the study is depicted in Figure 2
below. After participants have completed the telephone
screening and meet the study’s eligibility criteria, they
will be randomized into the IYP or usual care control
group. All participants will be asked to fill out consent
forms before their initial medical assessment, which
includes a phlebotomy, measurement of blood pressure/
resting heart rate, and a joint count conducted by a phy-
sician who will be kept unaware of group assignment.
Before the medical assessment, a research assistant will
send a link to the questionnaires for participants who
choose to complete them online. A hard copy of the
questionnaires will be taken to the medical assessment if
the participant chooses to complete the paper-based
version in a private medical office.
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Those assigned to the IYP will then engage in the
6-week program; they will repeat the baseline assess-
ments immediately following treatment and again at a
two-month follow-up. Patients initially assigned to
the wait-list group will continue their usual care.
Both the yoga and control groups will either receive
weekly phone calls or e-mails to monitor symptoms,
medication use and physical activity. After 6 weeks,
control participants will be re-assessed to ensure that
they still meet study eligibility criteria; those that con-
tinue to meet criteria will then take part in the IYP.
Following the IYP, participants will then repeat the
baseline assessments at post-treatment and two-
month follow-up.
Enrollment criteria
Young women and men will be eligible for the study if
they meet the following criteria:
• Age 16-35 years.
• Diagnosis of RA, according to the revised 1987
ACR criteria for at least 6 months.
• Concomitant use of disease modifying antirheu-
matic medications (hydroxychloroquine, sulfasala-
zine, methotrexate, leflunomide, etc.) and/or biologic
agents (infliximab, etanercept, adalimumab, abata-
cept, rituximab, anakinra) is permitted provided that
the dose(s) have been stable for 8 weeks prior to
screening, and subjects may reasonably be expected
to remain on stable doses throughout the study.
• Concomitant use of NSAIDs and low dose corti-
costerioids (e.g., prednisone at doses of 10 mg/day
prednisone or equivalent) is permitted provided that
the dose(s) have been stable for 4 weeks prior to
screening, and subjects may be expected to remain
on stable doses throughout study duration.
• Disease activity, as defined using a 28 joint count
by ≥ 5 tender joints, ≥ 5 swollen joints, and one of
the following: Erythrocyte Sedimentation Rate (ESR)
≥ 28 mm/hour, C-reactive protein (CRP) ≥ 1.5 mg/
dL, duration of a.m. stiffness ≥ 45 minutes.
• Able and willing to give written informed consent
and comply with the requirements of the study.
• Ability to speak and understand English.
Exclusion criteria
Patients will be excluded from the study based on the
following criteria:
• Intra-articular steroid injections within 4 weeks of
screening.
• Treatment with any investigational agent within
8 weeks of screening or 5 half-lives of the investiga-
tional drug (whichever is longer).
• History of drug, alcohol, or chemical abuse within
6 months prior to screening.
• Any other disease, metabolic dysfunction, physical
examination finding, or clinical laboratory finding
giving reasonable suspicion that might affect the
Figure 2 Flowchart of study design.
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interpretation of the results or render the patient at
high risk from treatment complications.
• Inability to comply with study and follow-up
procedures.
• Currently pregnant.
• Previous practice of Iyengar yoga within the past
three months.
• Inability to speak and understand English.
According to the Power/Sample Size calculations out-
lined below, we will recruit 35 patients each for the IYP
and control conditions. After accounting for our
projected attrition rate of 20%, we estimate there will be
roughly 28 treatment completers in each condition. To
accommodate 56 participants during the 36-month
study period, we plan to conduct 4 initial IYP groups
and 4 initial control groups, with approximately
8 patients in each group.
Sample Size Determination and Power Analysis
A power analysis was conducted to determine the
appropriate sample size. Using a pre-test post-test for
randomized groups, calculating power of the interaction
of treatment by time, the sample size estimate is a total
sample of 54, or 27 subjects per group (at a 0.05 signifi-
cance level, 80% power for a medium effect size). We
calculated a medium effect size given that our recent
single-arm pilot study found an effect size of .46
(Cohen’s d) for the HAQ, our arthritis-specific primary
outcome measure. Assuming a 20% attrition rate that is
consistent with our previous yoga studies, we will recruit
35 participants for each group (total n = 70).
Randomization
Before completing the baseline assessments, participants
will be randomly allocated to the intervention or control
group. The research team will assign the patient to the
groups using randomization schedules generated by
UCLA Biomathematics for group assignment in blocks
of 4. As each patient is enrolled, he or she will be
assigned to the next number on the list and the asso-
ciated condition, yoga or usual care.
Recruitment
Participants will be recruited from the UCLA Division of
Rheumatology, the UCLA pediatric rheumatology pro-
gram, private medical offices of rheumatologists, UCLA
Student Psychological Services, health newsletter ads,
the young adult support network of the Southern Cali-
fornia Chapter of the Arthritis Foundation, and commu-
nity resources, such as library and other public notice
boards, as well as websites, such as Craigslist. The
UCLA Division of Rheumatology has a current patient
population of 150 individuals with RA who are 16-21
years of age. The UCLA pediatric rheumatology pro-
gram sees 100 patients with arthritis 16 years and older.
Private practice rheumatologists in Los Angeles who
have agreed to assist with our project can refer an addi-
tional 200 patients with RA in our targeted age range.
The Southern California chapter of the Arthritis Foun-
dation will help us recruit from their pool of several
hundred RA patients who regularly receive their email
announcements and mailed bulletins. In all, we antici-
pate being able to recruit from a pool of over 500 indi-
viduals with RA in the targeted age-range.
The project director will meet with health care provi-
ders, staff and support group leaders to inform them
about the project and to ask them to distribute and post
flyers about the study. The flyers will describe the pro-
ject and ask interested volunteers to call the project
manager to establish their eligibility. Additionally, a lay
advisory board comprised of young adults with RA will
be formed and consulted with in the development of
recruitment materials as well as in the finalization of the
protocol and research instruments.
Effort will be made to recruit the patient sample to be
broadly representative of the general population of RA
patients in the targeted age range. Epidemiological data
suggest that the racial composition of RA in the U.S. is
approximately 84.4% non-Hispanic whites, 8.3% non-
Hispanic blacks, 2.3% Mexican American and 5% other
[50]. Women are between 60-75% more likely to experi-
ence RA than men [50,51]. We will also attempt to
recruit patients to reflect the demographic composition
of the Greater Los Angeles area which is estimated to
be approximately 75% White, 13% Asian, 10% African-
American, 1% American Indian/Alaska Native, and 1%
Native Hawaiian/Other Pacific Islander; ethnic makeup
will be 45% Hispanic and 55% Non-Hispanic.
Intervention
Iyengar Yoga Program (IYP)
IY is a traditional form of yoga taught in the lineage of
BKS Iyengar, who is known for his prominent texts on
yoga and innovative teaching techniques. Iyengar has
developed specific methods of teaching therapeutic yoga
practices to people with health problems [52-54]. IY is
an ideal form of activity for people with RA, as the
emphasis on alignment in this practice protects joints, is
unlikely to irritate inflamed joints and involves sufficient
movement to tap the beneficial effects of exercise.
Young RA patients with fatigue, restricted motion and
painful joints can perform postures with the support of
props (blocks, bolsters, chairs, straps and blankets) that
allow postures to be held without stress. Yoga postures
are designed to promote circulation, stimulate the hor-
monal system and circulate lymph through body posi-
tion and muscle activity. The use of props allows
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inverted postures to be held for long periods of time
without fatigue so that the lymph is well circulated
without strain. Challenging back bending postures
designed to stimulate the adrenal glands can also be
held for longer periods of time with the support of
props. The poses to be included in this intervention
are based on the teachings of BKS Iyengar. The poses
include supine poses, passive backbends, standing
poses, seated poses, forward bends and supported
inversions. All will be done with use of props as
needed (see Figure 3).
Yoga taught in the Iyengar tradition is known for an
extensive teacher training program. Iyengar teachers
study for at least seven years before being certified to
work with students who have therapeutic needs. They
must pass several certification tests before an impartial
national board. These tests include teaching, perfor-
mance of poses and breathing techniques, anatomy and
therapeutic sequences. Because of this training, IY tea-
chers across the country and around the world can
accurately reproduce the IYP in this study.
The proposed IYP will be administered twice a week
for 1.5 hours duration per session for 6 weeks. Due to
the extensive time commitment required for the IYP,
there will be no instructions for home practice, but
neither will participants be discouraged from practicing
at home. At the end of the 6-week IYP, those partici-
pants who ask for referrals to IY studios/teachers in the
community will be given a list of referrals. All home
practice as well as post-IYP yoga classes will be moni-
tored during the weekly phone calls/e-mails and at the
post-treatment and follow-up assessments; the extent of
home practice will be evaluated in the analyses for its
potential impact on outcome.
Should subjects experience a flare-up during the IYP,
the research team will consult with the patient’s rheu-
matologist and a modified version of the IYP will be
offered to the subject consisting of restorative poses that
do not place strain on the affected joints.
Treatment administration
As illustrated in Figure 4, two streams of yoga classes
will run concurrently to minimize the overall length of
the study and to maximize the likelihood that yoga
classes will be convenient for patients’ schedules. For
example, Stream 1 classes will be held on Mondays and
Wednesdays, while Stream 2 classes will be held on
Tuesdays and Thursdays. Stream 1 and Stream 2 will
comprise the first Wave of patients (Wave 1). Upon the
completion of Wave 1, a second wave of patients (Wave
2) will consist of two additional Streams of classes. A
make-up class will be scheduled each week for any
patient not able to attend their usual session. Thus, all
patients should be able to receive the full course of IYP
since classes will be run 5 days per week (e.g., make-up
classes held on Fridays). We will make note of how
many make-up classes each patient attends and test for
possible differential effects due to missing regular
classes. Patients in the control groups will be given the
opportunity to take part in the IYP at the end of the
6-week control period. To increase patient safety and
accurate practice of poses, IY classes will hold a maxi-
mum of 9 patients.
Usual care control
Patients initially assigned to this condition will be
instructed to continue with their on-going medical care.
During the control period, these patients will be tele-
phoned or emailed by study personnel to complete the
weekly monitoring form (described below) to monitor
symptoms, functioning and mood.
Primary outcomes
1. Health Related Quality of Life - Short Form-36
(SF-36) [55] is a generic core HRQOL measure yielding
an 8-scale profile of functional health and well-being.
The SF-36 performs comparatively better than other
HRQOL measures in terms of reliability, validity and
lightness of respondent/administrative burden [56]. It
Figure 3 Selected yoga poses.
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can be completed in 5-10 minutes and has been used
with children as young as 10 years of age [57].
2. Pain-related functioning will be measured by the
Pain Disability Index (PDI) [58]. The PDI assesses the
impact of pain on ability to participate in basic life activ-
ities, including social activity, sexual behavior, self-care
and life-support activity. The PDI has been used with
patients as young as 15 [59]. Good internal reliability
(a = .82) and validity have been reported [58,60]. It
takes less than 5 minutes to complete.
3. Arthritis functioning will be assessed with the
Health Assessment Questionnaire (HAQ) [45]. Items
include questions about dressing and grooming, rising,
eating, walking, hygiene, reaching, grip and activities.
The HAQ is one of the most widely recognized mea-
sures of patient functioning, with acceptable reliability
and validity [45]. It has been used successfully with ado-
lescents as young as 13 years of age [61].
Secondary outcomes
1. Disease Activity Scale (DAS) 28 is a combined index
that measures disease activity in patients with RA and
remains a more thorough, established alternative to
standard medical exams. This index includes a 28 tender
joint count, 28 swollen joint count, Erythrocyte Sedi-
mentation Rate (ESR) and general health assessment
using a visual analogue scale. The ESR indirectly mea-
sures inflammation in the body and involves collecting
blood samples, which will be performed by a qualified
phlebotomist.
2. Pain will be measured with a numeric rating scale
(NRS) that asks on a scale of 0 (no pain) to 10 (worst
pain possible), what is your current level of pain?
3. Mood will be evaluated using the Brief Symptom
Inventory 18 (BSI-18) [62]. Respondents rate how often
they have experienced anxiety, somatization and depres-
sive symptoms within the past 7 days on a 5-point
Likert scale ranging from ‘Not at all’ to ‘Extremely.’ The
BSI-18 has shown adequate to good internal consistency
(a range = .74 - .89) and validity [62]. The BSI-18
requires a 6th grade reading ability and takes approxi-
mately 4 minutes to complete.
Exploratory variables
1. Blood Pressure and Resting Heart Rate will be
taken at each medical assessment to evaluate changes in
autonomic nervous system activity using a non-invasive,
portable, digital blood pressure monitor. A mean blood
Note: Follow-up assessments are not shown for control groups who go on to complete the IYP. 
Yoga 1 (n=9)
Wave 1 Follow-up 
Wave 2 Follow-up 
Yoga 2 (n=9)
6 weeks IYP 
6 weeks IYP 
6 weeks IYP
6 weeks IYP
Month 9 
M11 
M13 
M18 
Month 14 
M16 
Control 2 (n=9)
6 weeks usual care
6 weeks usual care
WAVE 2: Cohort 2
Yoga 4 (n=8) Control 4 (n=8)Yoga 3 (n=9)
Stream 1 Stream 2
Stream 1 Stream 2
6 weeks IYP
6 weeks IYP 
Control 1 (n=9)
6 weeks usual care
Control 3 (n=9)
6 weeks IYP 
6 weeks IYP 6 weeks usual care
WAVE 1: Cohort 1 
Figure 4 Group entry timeline.
Evans et al. Trials 2011, 12:19
http://www.trialsjournal.com/content/12/1/19
Page 9 of 16
pressure/resting heart rate value will be derived by tak-
ing 2 readings, each 1 minute apart.
2. Cytokine Assays will be collected from subjects
before and after the intervention, at the same time that
the blood draws for ESR will be carried out. For the eva-
luation of pro-inflammatory cytokines, interleukin1-
receptor antagonist (IL-1 RA), interleukin-6 (IL-6) and
isolated PBMC will be incubated with LPS (500 μl) to
yield a final concentration of 5 μg/ml (Ackerman et al.,
1998). This dose of LPS has been found to yield optimal
production of IL-1, and IL-6 following a 48-hour incu-
bation. Concentrations of these pro-inflammatory cyto-
kines from stimulated cell cultures will be determined
by ELISA (R & D Systems). For IL-6, the ELISA intra-
assay CV% is 3.1, inter-assay CV% is 2.5, sensitivity <0.7
pg/ml; for IL-1, the intra-assay CV% is 2.3, inter-assay
CV% 4.1, sensitivity <1.0 pg/ml. For these assays, we
will use high sensitivity kits. The subjects will be
brought to a hospital laboratory where a trained phlebo-
tomist will conduct the blood draws needed to assess
disease activity in participants. For participants in the
intervention group, these blood draws will be performed
during a baseline assessment and again at the end of the
yoga intervention. Wait-list controls will have their
blood drawn at study entry, as well as before and after
the yoga intervention.
3. Arthritis Self-efficacy Scale (ASES) [63] is
designed to assess arthritis patients’ beliefs that they can
perform specific tasks or behaviors to cope with the
consequences of chronic arthritis. The scale has 20
items to measure three subscales: pain, function and
other symptoms. Reliability is good (a range = .76 -
.89). The scale takes approximately 5 minutes to
complete.
4. Coping Strategies Questionnaire (CSQ) [64] is a
42-item checklist measured on a 0-6 Likert scale
designed to measure coping in relation to pain. Validity
and reliability has been supported in a number of differ-
ent pain populations, including arthritis patients [64-67].
A child version of the scale (CSQ-C) [34] has been vali-
dated and will be used for patients aged 16-20 years.
The questionnaire takes approximately 10-15 minutes to
complete.
5. The Chronic Pain Acceptance Questionnaire
(CPAQ) [68] is a 20-item measure with two subscales:
Activity Engagement assessing patients’ participation in
activities regardless of pain and Pain Willingness, asses-
sing absence of attempts to control or avoid pain. The
CPAQ has acceptable reliability (a=.78-.82) and validity
[68]. It takes approximately 5-10 minutes to complete
and is suitable for older adolescents as young as 16
years of age.
6. Pittsburgh Sleep Quality Index (PSQI) [69]
assesses subjective sleep quality over the past month.
This 19-item index measures seven components: subjec-
tive sleep quality, sleep latency, sleep duration, habitual
sleep efficiency, sleep disturbance, use of sleeping medi-
cations and daytime dysfunction. Individual component
scores or global scores ranging from 0-21 can be evalu-
ated with higher scores indicating poorer sleep quality.
The overall reliability coefficient (Cronbach a) is
0.83 and test-retest reliability has a Pearson correlation
of 0.85. The index can be completed in less than
5 minutes.
7. Functional Assessment of Chronic Illness Therapy
Fatigue Subscale (FACIT-Fatigue) [70] includes 13
items that assess physical and functional consequences
of fatigue. Scores range from 0-52 on a reverse 4-point
Likert scale, with higher scores indicating less fatigue.
The FACIT-Fatigue has excellent test-retest reliability
(r = 0.90) and internal consistency (a = 0.93-0.95).
8. Mindfulness will be assessed using the Five Factor
Mindfulness Questionnaire (FFMQ) [71,72], a 39-item
self-report measure derived from a factor analysis of
items from previously developed mindfulness question-
naires. Items are rated on a Likert scale ranging from
1 (‘never or very rarely true’) to 5 (’very often or always
true’). There are five subscales relating to the five facets
of mindfulness: Observe, Describe, Act with Awareness,
Nonjudging and Nonreactivity. The FFMQ has been
shown to have good internal consistency, with alpha
coefficients ranging from .75 to .91, and relationships
between the facet scales and other variables are consis-
tent with predictions in most cases. It has been used
with high school-aged students previously [73]. It takes
less than 10 minutes to complete.
9. Medication use will be assessed during the
patients’ weekly phone call/e-mail during which the
Weekly Monitoring Form will be administered. These
weekly forms will be used to gather ratings of patients’
pain, fatigue, anxiety and depression using 0-10 scales;
we will also assess the extent of physical activity during
the past week and the extent (i.e., frequency/duration)
of any home practice of yoga.
A weekly monitoring form will include specific ques-
tions about functioning, mood, pain, improvement,
activity and medication use. The form is an important
tool as patients’ self-reported functioning will form the
basis for understanding the action of yoga over time on
symptoms. Thus, responses to the form will be used to
determine the minimum and maximum number of yoga
sessions needed to produce change. For participants
who prefer completing this form online, an online link
will be sent to them each week. Otherwise, the form
will be telephone-administered by a trained research
assistant once a week for two weeks preceding the inter-
vention to ascertain baseline functioning, and then once
a week during the intervention and control periods.
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Qualitative measures
While the quantitative data we propose to gather and
analyze should provide us with valuable information as
to the extent to which the IYP is impacting quality of
life and ability to function, qualitative interview data
should also serve to elucidate the quantitative data and
help us to tease out the nuances of the findings. That is,
we expect the semi-structured interviews to yield a rich
source of information that provides us with a more
comprehensive picture of the issues facing RA patients
and the process by which the yoga practice changes
their daily lives. Specific topics to be covered will
include: the nature of their symptoms and the life
domains they affect; how specifically and the extent to
which these life domains are impacted; the patients’
attempts at self-management of the symptoms; the
strength of their social networks and the impact of the
symptoms on these networks; and their perceptions of
the yoga program. Interviews will be conducted at the
end of the intervention by a social scientist experienced
in the design, collection, and analysis of qualitative data.
Data analyses
Quantitative statistical analysis
After the data have been entered and cleaned, the statis-
tical plan will unfold in two stages. The first stage will
involve assessing outcome measures for reliability and
general integrity (e.g., distribution characteristics) to
ensure that appropriate techniques are applied during
data reduction and model testing. The second stage will
consist of: 1) descriptive procedures to detail the dataset,
and 2) primary analyses to answer the research ques-
tions forming the basis of this proposal.
Each stage of data analysis detailed below will initially
be carried out separately for younger (16-18 yrs) and
older (19-21 yrs) sub-groups. If no differences are found
on analyses, the groups will be combined.
Preliminary analyses
Once the data set has been cleaned and examined for
skewness and missing data, exploratory data analyses
will be conducted using univariate methods to describe
the variables of interest and bivariate techniques to
characterize their interrelationships within our sample.
Continuous variables will be summarized over time in
each group using means and medians and we will also
report their range, interquartile range and standard
deviations. Cross tabulated frequencies will be given for
all discrete variables by group and time. Results from
these descriptive analyses will be used to guide the pri-
mary analyses by providing information about potential
problem measures (e.g., heavily skewed distributions) or
problematic variable relationships (e.g., highly correlated
predictors) and will help determine if transformations of
some outcomes are possible in order to use parametric
methods. We will test for baseline between-group differ-
ences in the outcome measures. Any variables found to
vary significantly by group will be included as covariates
in primary and secondary analyses. This will also serve
to verify that the randomization was successful.
Missing data will be handled using multiple imputa-
tion [74] using the SAS routines PROC MI (20 imputa-
tions) and PROC MIANALYZE (to combine estimates).
The imputation process is fostered by including addi-
tional variables (not part of the intended analytic model)
that are highly correlated with variables that have miss-
ing data or that are associated with the probability that
those variables have missing data. Such covariates (used
in imputation only) will vary from analysis to analysis
and their viability will be evaluated by preliminary analy-
sis (e.g., zero-order correlations with variables with
missing data) and their impact on the imputation model
(e.g., change in standard errors of imputed variables).
Multiple imputation has been shown to perform well
with small samples [74].
For Hypothesis 1: The IYP will be safe, acceptable and
feasible: more than 80% of subjects will complete the
training program, we will examine the frequencies of
drop-outs for the IYP and control groups. We will com-
pare attrition rates between the groups; we will also
compare demographic characteristics and baseline values
of functioning between those who complete the protocol
and those who do not. If drop-outs are random, then
the results may be considered unbiased. If drop-outs are
not random, we will comment on the direction and
magnitude of potential biases.
Primary analyses
To test Hypothesis 2: Participants in the IYP will
demonstrate significantly greater improvement in
HRQOL and functioning compared to controls. The pri-
mary outcomes include the SF-36, PDI and the HAQ.
Two sets of analyses will be conducted. The first set of
analyses will compare the initial yoga and control
groups immediately after the IYP and control phase,
respectively. Separate mixed group (yoga vs. control) by
time (baseline vs. post-treatment/post-control) repeated
measure analysis of variance (ANOVA) will be con-
ducted on the primary outcomes, or the non-parametric
equivalent (Friedman procedure), in the event the
assumptions for parametric analyses are not met. We
will use the Tukey-Fisher criteria for post hoc mean/
median comparisons under the ANOVA or Friedman
model. Consistent with Hypothesis 2, we expect a group
by time interaction wherein the yoga group will report
improved functioning from baseline to post-treatment
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compared to the control group. The second set of ana-
lyses will assess maintenance of treatment gains during
the follow-up period. If yoga and control groups do not
differ significantly on SF-36, PDI and HAQ scores at
baseline, then data from the two groups will be com-
bined in order to maximize power. If groups differ at
baseline, each group will be analyzed separately.
Changes in SF-36, PDI and HAQ scores across baseline,
post-treatment and follow-up will be evaluated using
separate within-group repeated measures ANOVAs;
Friedman’s procedure will be used if parametric assump-
tions are not met. Consistent with Hypothesis 2, we
expect significant improvements in functioning scores
from baseline to post-treatment, persisting at follow-up.
We will also conduct an intent-to-treat (ITT) analy-
sison primary outcomes to confirm our findings in com-
pleters by including all participants who enrolled in the
study, using the last observation carry forward approach.
Participants who drop out will be included in the analy-
sis by utilizing outcome scores before attrition.
Secondary analyses
To test Hypothesis 3: Participants in the IYP will report
significantly less pain, improved joint count, and mood
compared to controls. The same methods used for the
primary analyses will be used for the secondary analyses
on pain intensity (averaged across the weekly NRS rat-
ings taken during the initial 6-week IYP/control period)
and mood. Consistent with Hypothesis 3, we expect
that the yoga group will evidence greater improvements
on these measures over the 6-week treatment period
relative to controls. We will also conduct similar within-
group repeated measures analysis, as described in the
primary analyses above, to examine changes in the sec-
ondary measures from baseline to post-treatment and
follow-up. Consistent with Hypothesis 3, we also expect
that benefits will be maintained over the two-month fol-
low-up period.
Exploratory analyses for potential mediators and
moderators
We will also examine potential mediators and modera-
tors of treatment outcome. Regression analyses will be
conducted to determine whether sociodemographic or
clinical characteristics mediate or moderate treatment
outcome. We will follow the procedures outlined in
Cohen and Cohen [75] to calculate residualized change
scores for the SF-36, PDI and the HAQ. Multiple
regression analysis will then be conducted with out-
comes separately; change scores (baseline minus post-
treatment) will be regressed onto a set of predictor vari-
ables including group (yoga vs. control), the mechanism
of interest (e.g., self-efficacy) and the interaction
between the mediator/moderator and group. A
significant interaction term indicates moderation [76]
and post-hoc analyses will be conducted to examine the
moderator variables. If evidence of mediation is found
using the traditional Baron and Kenny approach, the
Sobel test, a statistical test for mediation will be con-
ducted to yield a more precise picture of mediation.
Exploratory analyses will be conducted in the data
derived from the weekly monitoring forms; for example,
we will examine whether changes in overall physical
activity may moderate treatment outcome.
Qualitative analyses
Digitally recorded qualitative data will be transcribed and
entered into computer files. Data in these forms consist
of large verbal texts that must be interpreted, organized,
and summarized using a text-based analysis technique.
The technique most appropriate to our data and research
goals is ethnographic content analysis (referred to as
template text analysis by Crabtree and Miller, 1992)
because we wish to systematically integrate it with the
close-ended HRQOL and functionality data. This techni-
que involves the creation of a codebook based on vari-
ables identified by the researcher as relevant to the
research questions and goals. Texts are read and codes
are assigned to relevant portions of the text and entered.
The process is iterative, however, and code categories are
revised, expanded, and created as research progresses.
This requires that coding proceeds from the very begin-
ning of the research and updating of previously coded
materials is carried out as the coding is refined.
We will employ Dedoose, one of the most effective
qualitative data analysis tools currently available.
Employing a web-based interface, Dedoose was designed
primarily for team-based research projects and includes
features that allow for efficient coding, integration with
categorical and scale data, and database searching and
retrieving. Unique to Dedoose is the ability for research
team members with security clearances from the PI to
access the data. All transfer of project data is encrypted
for security. Further, the process of identifying and
exploring coding patterns is automated via easily gener-
ated tables and user-defined output is available at any
time in MS Word or Excel formats.
The process of coding allows for the thematic analysis
of data. To address inter-rater reliability concerns, we
will use multiple coders and measure intercoder agree-
ment (the extent to which a group of individual coders
concur in their identification of themes and codes).
Thus, we will be able to ensure a high level of reliability
in our qualitative data analysis.
Integrating methodologies
For this study, the qualitative interviews derive a num-
ber of themes from the HAQ and the PDI. Our
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intention in doing so is to delve into how pain limits the
HRQOL of young people with RA in much greater
depth than the quantitative measures alone allow and to
triangulate the findings. The qualitative instrument
seeks to capture in detail the nuances of the impact of
RA on the respondents’ life experiences in seven
domains: 1) family/home responsibilities, 2) recreation
(hobbies, sports), 3) social activity, 4) occupation, 5) sex-
ual behavior, 6) self-care, and 7) life-support activity
(eating, sleeping, breathing). We will explore in detail
the nature of the subjects’ symptoms and what life
domains the symptoms affect, how specifically these life
domains are impacted, the patients’ attempts at self-
management of the symptoms, impact of the symptoms
on these networks, and the patients’ perceptions of the
effects of the yoga program.
The integration of qualitative and quantitative meth-
odologies represents a promising, though largely under-
utilized, avenue for researchers. An emergent and
compelling body of literature supports the value of
mixed methods [77-80] and suggests a panoply of
means by which the techniques can be effectively com-
bined. In this study, we are electing to administer quan-
titative measures as well as a qualitative measure that
derives its basis from the quantitative measure in order
to: a. cross-validate the qualitative and quantitative data
(triangulation), b. clarify the data from one method with
the data of another (complementarity), and c. broaden
the depth of the data (expansion) [79]. Overall, we
intend to optimize our understanding of the effects of
the IYP for this population; we believe this integrated
methodological approach will yield a much richer set of
data than if we were to follow either strategy alone and
distinguishes our proposed study as unique.
Protection of subjects
This study was approved by the South General Institu-
tional Review Board within the Office of the Human
Research Protection Program at UCLA (IRB Number
G08-02-045-03). The study will be carried out in com-
pliance with the Helsinki Declaration.
Potential risks
Yoga is generally regarded as safe and adverse effects are
rare, especially within the Iyengar program in which
props are used for support and teachers undergo vigor-
ous training. A number of case reports have indicated
adverse events following yoga, specifically, the presence
of subcutaneous emphysema [81] and shortness of
breath and chest pain [82]. However, these events were
in response to intensive pranayama, or breathing exer-
cises, with the shortness of breath case experiencing dif-
ficulty following kapalabhati pranayama, involving
strong forced breaths which may push the body to
physiologic extremes [82]. Such intensive breathing
techniques will not be used in this yoga intervention.
Back bending postures, such as those used in IY can be
harmful if conducted without progressive musculoskele-
tal actions [83], and great care will be taken in develop-
ing the yoga program to ensure that muscles are not
stressed. A qualified assistant in addition to the instruct-
ing teacher will also be present during all sessions to
ensure that patients are completing the poses correctly.
Participants may feel uncomfortable disclosing personal
information about their mood and symptoms on study
questionnaires and during interviews. The 28 joint
count medical exam and blood draws may cause some
temporary discomfort at the time of examination.
Protection against risks
The major potential risks from the yoga class are mus-
culoskeletal strains or injuries. We will minimize these
risks by conducting the yoga intervention in the safest
manner possible. A progressive series of poses has been
developed for this trial; this gradual progression tailored
to the participants is designed to avoid musculoskeletal
injury. In addition, props will be used to support partici-
pants in more challenging poses. The general safety
parameters of the yoga program are: 1) heart rate will
not exceed moderate training range (115 BPM) - we will
ask participants to check their pulse at the end of each
yoga session during a timed one-minute period and to
report their heart rate; 2) attention will be paid to spinal
safety; 3) balance will be carefully monitored (e.g., chairs
are used to assist balance as needed). Students will be
given modifications of postures using props to accom-
modate for individual differences and limitations, and
receive individual attention if postures are too challen-
ging. An assistant will work with the experienced IY
teachers during all classes and will observe for any diffi-
culties and assist participants as needed.
To minimize any potential risks or discomfort asso-
ciated with study assessments, all assessments will be
conducted in a private room. Participants will be
encouraged to raise questions or concerns at any time
and be reminded that they may withdraw at any time
without penalty. A trained phlebotomist will collect all
blood samples and a rheumatologist will conduct the
medical exams.
Confidentiality will be maintained by the use of
unique identification numbers. All data and participant
lists will be kept in locked file cabinets with access
restricted to research staff. All data forms will have sub-
ject ID only. No data on individuals will be published.
All hard copies of the data will be kept in locked file
cabinets, even after the completion of the study. Data
obtained from participants will be stored in a computer
database, which will be password accessible only.
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Password-protected access will be given only to the
principal investigator and co-investigators on the study.
Electronic data will be collected using a secure survey
software and questionnaire tool called SurveyMonkey
with many system safeguards such as password protec-
tion, IP-masking, and data encryption (Secure Sockets
Layer or SSL), etc. The hypertext transfer protocol
secure (HTTPS) URL provides encryption and secure
identification of the server, as indicated by a lock icon,
to ensure confidentiality. SurveyMonkey is one of the
most common secure online questionnaire services used
to survey research participants and has physical and
environmental controls in place to protect data.
Yoga safety and adherence monitoring board
The Project Director will oversee the process of data
collection and ensure that data from the medical evalua-
tion, self-report questionnaires, and interviews are
reviewed for completeness and accuracy. Reviewed data
will be secured in locked file cabinets in the project
offices. During each of the treatment waves, we will
carefully monitor any potential threats to the safety and
well-being of participants. A board will be created with
the purpose of monitoring instructor adherence to the
study manual and safety of patients. The Board will
review the notes taken by assistants at each session for a
randomly selected sample of 20% of patients, to be
equally distributed across those who receive the IYP
first and those who receive the control condition first.
Using these notes, the Board will rate each instructor on
the extent of adherence to the yoga manual. The Board
will also review regular safety reports that will include
information regarding recruitment, demographics of
subjects, and any possible safety concerns including
adverse events.
Discussion
Young people with chronic, disabling RA symptoms
represent a significantly underserved population. The
overarching goal of this project is to develop and test a
novel prevention and risk reduction approach to
improving functioning and enhancing the quality of life
for this population. The data from this project will
inform a larger study to conduct a more formalized and
advanced trial to further evaluate the utility of IY for
improving pain and functionality among RA patients.
Ultimately, by amassing a strong evidence base, our IY
treatment protocol may eventually become integrated
into the established prevention and treatment approach
for RA as well as the management of other chronic and
debilitating conditions.
A number of limitations may pose challenges to carry-
ing out the proposed study. Given that RA is more typi-
cally diagnosed in older adults, recruiting participants
who meet our age criteria may prove difficult. It is
possible that attrition rates will be higher than pre-
dicted. A significantly greater drop-out rate would con-
tradict our hypothesis about feasibility and this finding
would force us to reconsider our design. Another poten-
tial study limitation is possible difficulties in scheduling
the IYP sessions to avoid conflict with school or work
and childcare issues. Classes will be scheduled on week-
ends and evenings at times when the majority of partici-
pants are available to address this potential difficulty.
Participants will also have the opportunity to attend one
make-up session if they miss any regular group classes.
Another potential limitation will be the development of
an arthritic flare during the IYP or control period. If a
participant develops a flare, he or she will be instructed
to communicate with his or her treating rheumatologist.
The principal investigator will set up a meeting with the
Data and Safety Monitoring Committee, which includes
a rheumatologist. The Committee will develop a modi-
fied treatment plan so that the participant can remain in
the IYP and continue with the program using modified
poses.
We recognize that the control group does not account
for the group or social aspects of the IYP. However, we
will assess the extent of the social support using qualita-
tive methods to determine the extent to which these
aspects may impact outcomes. The decision to include a
wait-list control group was based on the consideration
that including a group-based control intervention would
be premature at this early stage of the clinical trial pro-
cess. We plan to explore the initial feasibility, safety and
efficacy of the IYP before moving on to a large-scale
clinical trial employing a group-based control condition
that controls for group effects related to the IYP. It is
also possible that the results of the study will reveal null
findings and no significant differences will emerge
between the control and intervention groups. If this is
the case, analyses will be conducted to determine possi-
ble causes of negative findings. Perhaps the intervention
will only be effective for a sub-group (such as young
adults) or for a limited number of outcomes. These
findings will, in turn, inform future investigations of
yoga for RA. Even if null findings occur, post-hoc ana-
lyses will prove valuable in refining further work in this
area.
Despite these limitations, our study is an innovative
contribution to the field of yoga research. One of the
more novel aspects of the study is that we will use a
mixed methodology assessment. This approach will
allow us to learn more from the participants in ways
that will help ensure the success of future studies and
may lead to the formulation of additional hypotheses. A
key feature of this project is the building of this study
within a theoretical model that will guide us in testing
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specific pathways for IY effects, including the impact of
psychospiritual aspects of IY on functional and HRQOL
outcomes. These analyses represent the first step in the
eventual delineation of salient moderators and mediators
of the effects of yoga in this population. Based on the
present findings, the model can be more fully explicated
and tested in multi-center studies with larger samples.
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Index; RA: Rheumatoid Arthritis; RCT: randomized control trial; SF-36: short
form 36; SSL: Secure Sockets Layer.
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